NEUROCOGNITIVE DISORDER TREATMENT MARKET ANALYSIS
Global Neurocognitive Disorder Treatment Market: Regional Dynamics
North America is expected to hold a dominant position in the global neurocognitive disorder treatment market, owing to adoption of advanced technology and rising number of neurocognitive disorder patients. According to the World Health Organization (WHO), nearly 35.6 million people live with dementia worldwide. The number of geriatric population worldwide and related dementia patients is expected to rise up to 65.7 million in 2030 and 115.4million in 2050. Furthermore, according WHO, the prevalence of dementia is increasing exponentially with age and sex in North America region, doubling in every 5.5 years. Moreover, satisfactory reimbursement policies, rising adoption of advance precautious methods and increasing penetration of life science analytics for monitoring health changes continuously are factors driving the growth of market in North America.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
